Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Lilles, France Clinical Trials

A listing of Lilles, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (534) clinical trials

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Phase

0.0 miles

Learn More »

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients

This clinical trial is being conducted to learn more about a potential treatment (valoctocogene roxaparvovec) for people with severe hemophilia A. This research study will test and confirm the safety and effectiveness of the 6E13 vg/kg dose of the study drug (valoctocogene roxaparvovec) that contains the correct gene to make ...

Phase

0.0 miles

Learn More »

Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer

The study will proceed as follow: Initial check-up before the brachytherapy, including a clinical exam, collect of disease history and other informations that can be required for a good execution of the trial, and a usual patient care (chemotherapy with concomitant radiotherapy, biopsy, RMI, PET-scan and paraaortic lymphadenectomy). additional PET-scan ...

Phase N/A

0.0 miles

Learn More »

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis.

The main objective is to assess long term safety of treatment with oral nintedanib in patients with Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD).

Phase

0.0 miles

Learn More »

A Multi-center Open-label Extension Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622

This is an open-label extension study to Study 200622.In this study subjects from Study 200622 will be continued on 4-weekly dosing with open-label mepolizumab 300 milligram (mg) subcutaneously (SC) for an additional 20 Weeks after completing the 32 Week study assessments post-randomization, while they continue with their background HES therapy ...

Phase

0.0 miles

Learn More »

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

This is a two-part, multicenter, double-blind, parallel-group, placebo controlled study to evaluate the effect of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with Lennox-Gastaut syndrome (LGS).

Phase

0.0 miles

Learn More »

Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery

Our study is an open, multicenter, randomized, parallel-group, controlled trial. This study will include obese pregnant women recruited in 11 French university hospitals. Patients will be randomized into two-parallel groups. One group underwent the electronic-personalized program (the interventional group) and the other underwent standard care (the control group). Due to ...

Phase N/A

0.0 miles

Learn More »

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced Metastatic or Unable to Be Removed by Surgery

OBJECTIVES: Primary - Determine the rate of non-progression at 9 months in patients with unresectable, locally advanced, or metastatic angiosarcoma treated with sorafenib tosylate. Secondary - Determine the rate of non-progression at 60, 120, and 180 days. - Determine the median time to progression. - Determine overall survival. - Determine ...

Phase

0.0 miles

Learn More »

Letrozole Anastrozole Exemestane or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

OBJECTIVES: Primary - To evaluate verbal episodic memory in patients with breast cancer after 6 months of treatment with aromatase inhibitors (AI) vs tamoxifen citrate. Secondary - To evaluate cognitive functions of these patients at month 6 and 12 of treatment. - To evaluate the psychological and social impact on ...

Phase

0.0 miles

Learn More »

Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer

OBJECTIVES: Primary - Measure quality of life (QLQ-C30) at week 18 in patients with metastatic gynecological cancer receiving systematic nutritional supplements during first-line chemotherapy. Secondary - Study the maintenance or improvement of intake and nutritional status. - Study the quality of life during chemotherapy. - Evaluate tolerance and compliance to ...

Phase

0.0 miles

Learn More »